Bioanalysis Zone is part of Taylor & Francis Group.

  • Taylor & Francis
  • About us
  • Our journals
  • Our Digital Hubs

Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.

Taylor & Francis
logo
 
  • Home
  • Awards
  • Events
  • Features
    • An author's perspective
    • Ask the Experts
    • Conference reports
    • eBooks
    • Expert opinion
    • In the Zone
    • Journal articles
    • Journal content
    • Spotlights
    • Tech Digest

    Follow us on social media

  • Glossary
  • Topics
    • Applications
      • Advanced therapies
      • Biomarkers
      • Clinical
      • Diagnostics
      • Drug development
      • Forensics
      • Patient-centric sampling
      • Sports drug testing
      • Toxicology
      • Vaccines
    • Industry updates & regulations
      • Biopharmaceuticals
      • Collaborations & mergers
      • Data processing and interpretation
      • Regulated bioanalysis
    • Molecules
      • Antibodies | ADCs
      • Biosimilars
      • Large molecules
      • Metabolites
      • Oligonucleotides
      • Small molecules
    • Techniques
      • Automation
      • Chromatography
      • Imaging
      • LBA
      • Microsampling
      • MS (LC–MS/MS, HRMS, IMS)
      • Sample preparation

    Follow us on social media

  • Multimedia
    • Coffee chats
    • Infographics
    • Interviews
    • Panel discussions
    • Podcasts
    • Videos
    • Webinars

    Follow us on social media

  • News
  • Partners
  • Register
Our new In the Zone on targeted MS imaging is now live! Check it out!

Key qualities to ensure success when outsourcing immunogenicity assay development

23 Oct 2019
Biomarkers Clinical Diagnostics Immunogenicity

immunogenicity-infographic-viracor

< Back to – In the Zone: Immunogenicity

 

 

 

Top content

  • Accidental discovery: SwRI scientists stumble upon a chromatography game-changer
  • Culture medium analysis solutions
  • SPACs and the race to cell and gene therapy breakthrough

Related tags

assay CRO outsourcing Viracor Eurofins
Previous article Next article

Related articles

13 DEC 2012 EXPERT OPINION
Biomarker assay development and validation for large molecules in bioanalysis: what are the challenges and how are they overcome?
9 MAY 2013 GENERAL INTEREST
PRA secures grant to employ new graduates
15 OCT 2013 GENERAL INTEREST
New assay developed for rapid diagnosis of tuberculosis
22 JUN 2011 COLLABORATIONS AND MERGERS
Recommendations on: internal standard criteria, stability, incurred sample reanalysis and recent 483s by the Global CRO Council for Bioanalysis
24 NOV 2014 GENERAL INTEREST
7th GCC Insights: incurred samples use; fit-for-purpose validation, solution stability, electronic laboratory notebook and hyperlipidemic matrix testing
22 OCT 2013 COLLABORATIONS AND MERGERS
Collaboration announced to develop blood-based companion diagnostic tests
  • About
  • Advertising & Sponsorship
  • Learn
    • Awareness
    • Education zone
    • Professional development
  • Contact Us
  • Permissions
  • Products
  • Zone Leaders
  • Whitelist Emails
  • Accessibility

Contact

Contact Us

Office info

Bioanalysis Zone is powered by Taylor & Francis Group

Bioanalysis Zone, 2-4 Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, United Kingdom
  • Taylor & Francis Group
  • Cookie Policy
  • Privacy Policy
  • Terms & Conditions
  • © 2025 Bioanalysis Zone